BCR and cancer: In conclusion, we could demonstrate that the more generic network trained from BL-2 and BL-41 cell lines had better transfer capacity to DLBCL cell lines HBL-1 and OCILY3 than the literature network indicating that a model trained on BCR-activated B-cells is informative to be transferred to BCR-driven cancer models.